Izenivetmab (ZTS-00075623) is a caninized IgG2κ anti-NGFB monoclonal antibody.
References:
[1]. WHO Drug Information, Vol. 36, No. 3, 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
















